CAPTERA

Welcome to the Brand page for “CAPTERA”, which is offered here for Scientific and laboratory apparatus, devices and instruments for identifying, sequencing, analyzing, measuring and recording dna or other molecules for non-medical purposes, genome sequencers; laboratory instruments, devices for analysis of nucleic acids, nucleic acid analyzers; laboratory apparatus, nucleic acid sequencers; computer systems and software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; computer software for use in analyzing, managing and visualizing dna sequencing data;medical services for analysis of genetics; genetic testing for medical purposes; nucleic acid based testing for medical purposes; medical services in the field of nucleic acid analysis; medical services in the field of genetic screening;apparatus, devices and instruments for identifying, sequencing, analyzing, measuring and recording dna or other molecules for medical diagnostics purposes, genome sequencers; medical diagnostic and analytical apparatus for medical diagnostic purposes; medical equipment, devices for analyzing nucleic acids and for dna sequencing for the purpose of rendering medical treatment and diagnosis, nucleic acid analyzers and nucleic acid sequencers;scientific research and consultancy services related thereto in the fields of genome sequence analysis and reporting; medical research services in the fields of genome sequence analysis and reporting; providing dna screening for scientific research purposes; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory instruments and computer systems for use in science and clinical research; consultancy, information and advisory services in the field of analysis of biomolecules as it relates to dna screening and genome sequence analysis and reporting;.

Its status is currently believed to be active. Its class is unavailable. “CAPTERA” is believed to be currently owned by “ROCHE MOLECULAR SYSTEMS, INC.”